Look for:

Our offer for

ELI LILLY AND COMPANY


ISIN:
US5324571083
WKN:
532457108

2022/09/27 22:04:12
Price
311.10 USD
Difference 1.17% (3.60)

General attributes

ISINUS5324571083
SymbolLLY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)308,029 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)326.01 USD (100)
Ask (Ask size)335.05 USD (200)
Open309.15 USD
High313.95 USD
Low308.32 USD
Close (prev. day)307.50 USD
VWAP311.107477 USD
Volume (pcs)3,019,604
Trading volume939,363,176.49
Number of trades58,974
Last size324,936

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Annual report: ELI LILLY AND COMPANYPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Erste Group related products on underlying

Product type # products
Express bonds 2

Recent research



2022/09/27 22:04:12
Price
311.10 USD
Difference 1.17% (3.60)

General attributes

ISINUS5324571083
SymbolLLY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)308,029 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)326.01 USD (100)
Ask (Ask size)335.05 USD (200)
Open309.15 USD
High313.95 USD
Low308.32 USD
Close (prev. day)307.50 USD
VWAP311.107477 USD
Volume (pcs)3,019,604
Trading volume939,363,176.49
Number of trades58,974
Last size324,936

Performance and Risk

6M1Y3Y
Perf (%)+7.64%+37.41%+176.85%
Perf (abs.)+22.08+84.70+198.73
Beta0.520.580.67
Volatility28.7328.2133.74
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)307.48 USD (3,902,325)
Ø price 30 days | Ø volume 30 days (pcs.)311.23 USD (2,665,142)
Ø price 100 days | Ø volume 100 days (pcs.)311.04 USD (2,824,729)
Ø price 250 days | Ø volume 250 days (pcs.)281.25 USD (2,894,431)
YTD High | date335.33 USD (2022/07/15)
YTD Low | date231.87 USD (2022/02/14)
52 Weeks High | date335.33 USD (2022/07/15)
52 Weeks Low | date220.20 USD (2021/09/28)

Erste Group related products on underlying

Product type # products
Express bonds 2

All listings for ELI LILLY AND COMPANY

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/09/2717:35322.80 EUR0.1518
Vienna Stock Exchange2022/09/2717:32322.95 EUR0.047
Tradegate2022/09/2722:26324.40 EUR0.3674
Stuttgart2022/09/2710:55322.00 EUR0.027
SIX Swiss Exchange2022/09/1617:31300.00 CHF0.001
NYSE2022/09/2722:04311.10 USD939.3658,974
Munich2022/09/2708:01321.70 EUR0.001
London Stock Exchange2021/12/1015:37225.3104 CHF0.021
Hanover2022/09/2708:04320.75 EUR0.001
Hamburg2022/09/2717:32323.15 EUR0.012
Frankfurt2022/09/2716:27323.55 EUR0.024
Duesseldorf2022/09/2721:01325.40 EUR0.0011
Berlin2022/09/2710:27322.45 EUR0.022

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=262&ID_TYPE_IMAGE_LOGO=2

Contact Details

ELI LILLY & CO.
- -
Lilly Corporate Center - 46285 Indianapolis
Telefon: 1-317-276-2000
Fax: -
E-mail: communications_corporate@lilly.com

PDF Downloads

Annual report: ELI LILLY AND COMPANYPDF Download

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Members of Management Board

Katherine BaickerMember of Board of Directors
Marschall RungeMember of Board of Directors
Mary Lynne HedleyMember of Board of Directors
William KaelinMember of Board of Directors
Gabrielle Greene-SulzbergerMember of Board of Directors
Jackson TaiMember of Board of Directors
Jamere JacksonMember of Board of Directors
Jon FyrwaldMember of Board of Directors
Juan LucianoMember of Board of Directors
Karen WalkerMember of Board of Directors
Kimberly JohnsonMember of Board of Directors
Ralph AlvarezMember of Board of Directors
David A. RicksChairman of Managing Board
Daniel M. SkovronskyMember of Executive Committee
Alfonso G. ZuluetaMember of Executive Committee
Alonzo WeemsMember of Executive Committee
Anat AshkenaziMember of Executive Committee
Anat HakimMember of Executive Committee
Anne E. WhiteMember of Executive Committee
Diogo RauMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.